Correlation Between Cloud Technologies and Medicofarma Biotech

Can any of the company-specific risk be diversified away by investing in both Cloud Technologies and Medicofarma Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cloud Technologies and Medicofarma Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cloud Technologies SA and Medicofarma Biotech SA, you can compare the effects of market volatilities on Cloud Technologies and Medicofarma Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cloud Technologies with a short position of Medicofarma Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cloud Technologies and Medicofarma Biotech.

Diversification Opportunities for Cloud Technologies and Medicofarma Biotech

0.36

Correlation Coefficient

Cloud Technologies  Medicofarma Biotech

Weak diversification

The 3 months correlation between Cloud and Medicofarma is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Cloud Technologies SA and Medicofarma Biotech SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medicofarma Biotech and Cloud Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cloud Technologies SA are associated (or correlated) with Medicofarma Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medicofarma Biotech has no effect on the direction of Cloud Technologies i.e., Cloud Technologies and Medicofarma Biotech go up and down completely randomly.

Pair Corralation between Cloud Technologies and Medicofarma Biotech

Assuming the 90 days trading horizon Cloud Technologies SA is expected to generate 0.52 times more return on investment than Medicofarma Biotech. However, Cloud Technologies SA is 1.92 times less risky than Medicofarma Biotech. It trades about 0.04 of its potential returns per unit of risk. Medicofarma Biotech SA is currently generating about -0.08 per unit of risk. If you would invest  4,020  in Cloud Technologies SA on December 25, 2024 and sell it today you would earn a total of  180.00  from holding Cloud Technologies SA or generate 4.48% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	98.31%
Values	Daily Returns

Cloud Technologies SA  vs.  Medicofarma Biotech SA

Cloud Technologies

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Cloud Technologies SA are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Cloud Technologies may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Medicofarma Biotech

Risk-Adjusted Performance

Very Weak

Over the last 90 days Medicofarma Biotech SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Cloud Technologies and Medicofarma Biotech

The main advantage of trading using opposite Cloud Technologies and Medicofarma Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cloud Technologies position performs unexpectedly, Medicofarma Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medicofarma Biotech will offset losses from the drop in Medicofarma Biotech's long position.

The idea behind Cloud Technologies SA and Medicofarma Biotech SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.